500
Participants
Start Date
June 30, 2022
Primary Completion Date
August 2, 2024
Study Completion Date
December 10, 2024
Etripamil NS 70 mg
Etripamil NS 70 mg will be administered via the Aptar Pharma Nasal Spray Bidose System, supplied as prefilled devices packaged into child-resistant boxes with instructions for use provided in the study drug box.
Placebo
Placebo will be administered via the Aptar Pharma Nasal Spray Bidose System, supplied as prefilled devices packaged into child-resistant boxes with instructions for use provided in the study drug box.
Beijing Anzhen Hospital; Capital Medical University, Beijing
Baotou Central Hospital, Baotou
The First Affiliated Hospital of Baotou Medical College, Baotou
Beijing Hospital, Beijing
Beijing Tongren Hospital, Capital Medical University, Beijing
Chui Yang Liu Hospital Affiliated to Tsinghua University, Beijing
Peking Union Medical College Hospital, Beijing
The Central Hospital of China Aerospace Corporation, Beijing
The First Affiliated Hospital of Bengbu Medical College, Bengbu
The Third Xiangya Hospital of Central South University, Changsha
Xiangya Hospital, Central South University, Changsha
Changzhou No.2 People's Hospital, Changzhou
The First Affiliated Hospital of Chengdu Medical College, Chengdu
The First Hospital of Jilin University, Ch’ang-ch’un
Affiliated Zhongshan Hospital of Dalian University, Dalian
People's Hospital of Deyang City, Deyang
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Guizhou Provincial People's Hospital, Guiyang
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
The First People's Hospital of Hangzhou Linping District, Hangzhou
Zhejiang Provincial People's Hospital, Hangzhou
Huai'an First People's Hospital, Huai'an
Huainan First People's Hospital, Huainan
Huizhou Municipal Central Hospital, Huizhou
Jinan Central Hospital, Jinan
Shandong Province Qianfoshan Hospital, Jinan
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
Lanzhou University Second Hospital, Lanzhou
Lishui Municipal Central Hospital, Lishui
The First Affiliated Hospital of Henan Science and Technology University, Luoyang
Mianyang Central Hospital, Mianyang
The Nanchang Third Hospital, Nanchang
The Second Affiliated Hospital of Nanchang University, Nanchang
Jiangsu Province Hospital, Nanjing
Nanjing Drum Tower Hospital, Nanjing
Guangxi Zhuang Autonomous Region People's Hospital, Nanning
The second affiliated Hospital of Guangxi Medical University, Nanning
Nanyang Second General Hospital, Nanyang
Ningbo First Hospital, Ningbo
Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai
Shanghai Pudong New Area People's Hospital, Shanghai
Shanghai Tongren Hospital, Shanghai
Shangrao People's Hospital, Shangrao
Shanxi Cardiovascular Hospital, Taiyuan
Jiangsu Taizhou People's Hospital, Taizhou
Binhai Hospital (Tianjin Fifth Central Hospital), Tianjin
Tianjin Medical University General Hospital, Tianjin
CR and WISCO General Hospital, Wuhan
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Xingtai Third Hospital, Xingtai
The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu
ZiBo Central Hospital, Zibo
Lead Sponsor
Collaborators (1)
Milestone Pharmaceuticals Inc.
OTHER
Corxel Pharmaceuticals
INDUSTRY